Navigation Links
FDA Will Wait for Trial Results on Vytorin
Date:1/25/2008

Early findings saw no medical benefit; heart expert calls it 'second-line' medication

FRIDAY, Jan. 25 (HealthDay News) -- The controversy surrounding the highly promoted cholesterol-lowering drug Vytorin continued Friday when U.S. health officials said they would review the medication's effectiveness, but only after final trial results were completed.

The debate began earlier this month when preliminary results of the so-called Enhance trial showed that Vytorin -- a combination of two cholesterol drugs -- had little medical benefit.

"We have not yet received a final study report and can't explain why Vytorin didn't lead to lesser amounts of plaque compared to patients treated with simvastatin alone," Dr. John Jenkins, director of the FDA's Office of New Drugs, Center for Drug Evaluation and Research, said during an afternoon teleconference.

A study released Jan. 14 by the makers of Vytorin found that the drug -- a combination of the Zocor (simvastatin) and Zetia (ezetimibe) -- may be no more effective at reducing the build-up of plaque in the arteries than Zocor alone. About 60 percent of U.S. patients who are taking Zetia now receive the drug as part of Vytorin.

The FDA expects to receive the final report on Vytorin in the next several months, Jenkins said.

"Once we receive the final study report, we estimate it will take as long as six months for us to fully evaluate the results of the Enhance study," he said. "And we will be considering whether any further action is warranted in regard to Zetia or Vytorin, and also whether this study has any impact on our approach to the approval of lipid-lowering drugs."

The Enhance trial found that although cholesterol was lowered, the pace at which artery-clogging plaques formed within vessels almost doubled in patients taking Vytorin, compared to those taking Zocor alone.

The FDA noted the trial was not designed to detect any differen
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Anti-Clotting Drug Trial Shortened by Bleeding Problems
2. Malaria Vaccine Shows Promise in Small Trial
3. Debate over safety of gene therapy trials focuses on issue of informed consent
4. Immunosyn Announces the Successful Completion of First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
5. MAP Pharmaceuticals Reaches Agreement with FDA on Special Protocol Assessment for MAP0004 Phase 3 Clinical Trial in Patients With Migraine
6. Black Americans Still Wary of Clinical Trials
7. Vaccines for Ovarian and Breast Cancer in Early Trials
8. Industrial Solvent May Increase Risk for Parkinsonism
9. Industrial Solvent May Increase Risk for Parkinsons Disease
10. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
11. New study: US ranks last among other industrialized nations on preventable deaths
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Will Wait for Trial Results on Vytorin
(Date:9/2/2014)... Welcome to Arthritis Awareness Month . ... living with the disease, The Arthritis Society is kicking ... featuring well-known Canadians from different walks of life telling ... Robertson , veteran news anchor ,      ...      Amy Cotton , two-time Olympic wrestler ...
(Date:9/2/2014)... overdoses has become an increasing concern to health officials ... York City Department of Health and Mental Hygiene, the ... nearly triple the number of such deaths in 2000. ... dramatic rise in nonmedical prescription opioid (PO) use among ... use among youth who transitioned from POs to heroin. ...
(Date:9/2/2014)... have made it clear that a mother,s eating habits ... a profound impact on her offspring and their propensity ... now, the mechanisms behind this phenomenon were unclear. According ... of The FASEB Journal F , scientists ... a mother,s diet and an offspring,s risk of future ...
(Date:9/2/2014)... September 02, 2014 HMP Communications ... education, is proud to announce the acquisition of ... center designed for healthcare professionals who integrate diet and ... comprehensive access to:, , Late-breaking news ... Dedicated topic centers for diabetes, oncology, renal disease, wound ...
(Date:9/2/2014)... from cancer surgery may be influenced by more ... Family conflicts and other non-medical problems may raise ... study has found. Addressing such quality-of-life issues before ... recoveries and save health care dollars, the research ... patients, and found that patients with a poor ...
Breaking Medicine News(10 mins):Health News:‘Voices of Arthritis’ Launches Awareness Month 2Health News:‘Voices of Arthritis’ Launches Awareness Month 3Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2
... ... ... , ... , , , , , ...
... ... ... ... ...
... ... ... ... ...
... Thousands of men, women and children experience family ... of Justice. Traditionally, therapy for violence survivors has ... In contrast, a University of Missouri researcher broadens ... their resilience, resourcefulness, and ability to overcome adversity. ...
... including consuming less salt and getting more exercise , MONDAY, ... salt and cutting down on that consumption should be a ... That,s one of the key messages of an Institute of ... Control and Prevention and released Monday, that calls hypertension -- ...
... , , ... ... ... ...
Cached Medicine News:Health News:Statement from Larry Minnix, President & CEO, American Association of Homes and Services for the Aging, on President Obama's Health Care Reform Proposal 2Health News:The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area 2Health News:The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area 3Health News:The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area 4Health News:The American Association on Health and Disability (AAHD) and the Susan G. Komen for the Cure Partner to Increase Accessibility for Women with Disabilities at Mammogram Facilities in the DC Metro Area 5Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan 2Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan 3Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan 4Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan 5Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan 6Health News:Husbands' hostile, anti-social behaviors increase wives' symptoms of depression, researchers find 2Health News:Report Calls High Blood Pressure a 'Neglected Disease' 2Health News:Report Calls High Blood Pressure a 'Neglected Disease' 3Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 2Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 3Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 4Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 5Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 6Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 7Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 8Health News:Spanish Only, Please: Special Latino Clinic Launched For Potential Abdominal Transplant Patients 9
(Date:9/2/2014)... , Spanien, September 2, 2014 /PRNewswire/ ... auf dem ESC-Kongress 2014 präsentierte GARFIELD-AF-Register ... und Behandlungsergebnisse von schlaganfallgefährdeten Patienten in ... Die Daten der ... einer innovativen und unabhängigen Forschungsinitiative zur ...
(Date:9/2/2014)... Pa. , Sept. 2, 2014 Particle ... adds to its investment in development and manufacturing capabilities ... to Karl Mueller , Particle Sciences, Associate Director ... nice pace adding clean room square footage, equipment and ... our clients.  The company now has over 6000ft 2 ...
(Date:9/2/2014)... Sept. 2, 2014  Edison Nation Medical, the ... with the American Association for Respiratory Care ( ... care specialists. Edison Nation Medical, which brings 12+ ... to commercialize their innovation ideas, will work with ... more than 50,000 respiratory therapists in bringing their ...
Breaking Medicine Technology:Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 2Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 3Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 4Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 5Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 6Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 7Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 8Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 9Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 10Daten aus dem globalen Register zur Behandlung von Vorhofflimmern zeigen, dass antithrombotische Wirkstoffe zur Verhinderung von Schlaganfällen nicht optimal genutzt werden 11Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 2Edison Nation Medical and AARC Team Up To Promote Innovation in Respiratory Care 3
... 300 watt xenon Light ... Endoscopy shares your commitment to ... highest quality care available through ... of advanced surgical instruments and ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
The new X7000 light source is specifically tuned for the demanding requirements of Progressive Scan High Definition. The X7000 Lightsource uses a 300 Watt Xenon Elliptical Bulb for crystal clear illu...
... shaver systems to a new level of ... Powershaver SL. Just the latest product offering ... surgical endoscopy, the Powershaver SL represents our ... field of arthroscopic surgery. ,Whether the application ...
Medicine Products: